Horizon Discovery Inks Additional Licensing Pacts with U of Washington | GenomeWeb

NEW YORK (GenomeWeb News) – Horizon Discovery and the University of Washington said today that they have entered into a pair of additional licensing agreements in the area of human gene targeting.

The new agreements give Cambridge, UK-based Horizon the exclusive right to commercialize inventions made by UW researcher David Russell, relating to the use of parvoviral vectors in human genome engineering.

In exchange, UW will be granted an undisclosed number of shares in Horizon and will receive ongoing product royalties from licensed products and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.